Dr Ankit Dutta
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
47 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.
DOI: 10.1038/s41467-026-71483-z2026
Research grants (other domestic)
Monitoring Immune Cell Dynamics and Treatment Response of Breast Cancer Using Cell-Free DNA
2025
Journal article
Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial
DOI: 10.1038/s41467-024-55308-52025
Journal article
Identification of persister cells and evolution of tumor clones during immunotherapy and at minimal residual disease timepoints decoded by single-cell whole-genome sequencing in multiple myeloma
DOI: 10.1182/blood-2025-39302025
Journal article
Characterization of the plasma proteome of multiple myeloma and its precursor conditions and identification of a prognostic high-risk signature of progression
DOI: 10.1182/blood-2025-21682025
Journal article
Profiling Minimal Residual Disease with Single-Cell Whole-Genome Sequencing of Circulating Tumor Cells in Patients Receiving BCMA- or GPRC5D-Targeted Agents
DOI: 10.1016/s2152-2650(25)03660-22025
Journal article
SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursors
DOI: 10.1038/s43018-025-01006-0
RECENT SCHOLARLY WORKS
2025
Journal article
Large-scale dependency and drug screens to characterize the therapeutic vulnerabilities of multiple myeloma with 1q
DOI: 10.1182/blood.20240251022025
Journal article
Genomic landscape of multiple myeloma and its precursor conditions
DOI: 10.1038/s41588-025-02196-02025
Journal article
Abstract 2015: Single-cell atlas of tumor and immune cells in disease progression from MGUS to MM
DOI: 10.1158/1538-7445.am2025-20152024
Journal article
Single-Cell RNA-Sequencing of 6 Million Tumor and Immune Cells in 365 Patients with MGUS and SMM Demonstrates Complex Progressive Changes in Immune Cell Functionality with a Distinct Footprint on Tumor Cell Biology and Disease Control
DOI: 10.1182/blood-2024-208837